Hess D - Search Results

1

Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.

Bartlett AS, McCall JL, Ameratunga R, Howden B, Yeong ML, Benjamin CD, Hess D, Peach R, Munn SR. Bartlett AS, et al. Among authors: hess d. Liver Transpl. 2002 May;8(5):458-68. doi: 10.1053/jlts.2002.32979. Liver Transpl. 2002. PMID: 12004346 Free article.

2

Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.

Bartlett AS, McCall JL, Ameratunga R, Howden B, Ramadas R, Yeong ML, Benjamin CD, Hess D, Munn SR. Bartlett AS, et al. Among authors: hess d. J Surg Res. 2003 Nov;115(1):1-8. doi: 10.1016/s0022-4804(03)00131-8. J Surg Res. 2003. PMID: 14572766

3

Prevention of autoimmune diabetes in the DRBB rat by CD40/154 blockade.

Moore WV, Chu W, Tong PY, Hess D, Benjamin C, Khalili J, Kover K. Moore WV, et al. Among authors: hess d. J Autoimmun. 2002 Nov;19(3):139-45. doi: 10.1006/jaut.2002.0605. J Autoimmun. 2002. PMID: 12419284

4

Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat.

Kover KL, Geng Z, Hess DM, Benjamin CD, Moore WV. Kover KL, et al. Among authors: hess dm. Diabetes. 2000 Oct;49(10):1666-70. doi: 10.2337/diabetes.49.10.1666. Diabetes. 2000. PMID: 11016450

5

Variation in the ordered structure of complexes between CD154 and anti-CD154 monoclonal antibodies.

Ferrant JL, Wilson CA, Benjamin CD, Hess DM, Hsu YM, Karpusas M, Roux KH, Taylor FR. Ferrant JL, et al. Among authors: hess dm. Mol Immunol. 2002 Sep;39(1-2):77-84. doi: 10.1016/s0161-5890(02)00045-7. Mol Immunol. 2002. PMID: 12213330

6

CD40/154 blockade and rejection of islet allografts in the streptozotocin and autoimmune diabetic rat.

Kover KL, Geng Z, Hess D, Benjamin C, Moore WV. Kover KL, et al. Among authors: hess d. Pediatr Diabetes. 2001 Dec;2(4):178-83. doi: 10.1034/j.1399-5448.2001.20407.x. Pediatr Diabetes. 2001. PMID: 15016184

7

The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge.

Ferrant JL, Benjamin CD, Cutler AH, Kalled SL, Hsu YM, Garber EA, Hess DM, Shapiro RI, Kenyon NS, Harlan DM, Kirk AD, Burkly LC, Taylor FR. Ferrant JL, et al. Among authors: hess dm. Int Immunol. 2004 Nov;16(11):1583-94. doi: 10.1093/intimm/dxh162. Epub 2004 Oct 5. Int Immunol. 2004. PMID: 15466914

8

Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys.

Gobburu JV, Tenhoor C, Rogge MC, Frazier DE Jr, Thomas D, Benjamin C, Hess DM, Jusko WJ. Gobburu JV, et al. Among authors: hess dm. J Pharmacol Exp Ther. 1998 Aug;286(2):925-30. J Pharmacol Exp Ther. 1998. PMID: 9694951

9

Photobiomodulation: shining a light on depression.

Wang L, Mao L, Huang Z, Switzer JA, Hess DC, Zhang Q. Wang L, et al. Among authors: hess dc. Theranostics. 2025 Jan 1;15(2):362-383. doi: 10.7150/thno.104502. eCollection 2025. Theranostics. 2025. PMID: 39744683 Free PMC article. Review.

10

CT-Based Body Composition and Frailty as Predictors of Survival Among Older Adults With Gastrointestinal Malignancies.

Giri S, Harmon C, Hess D, Cespedes Feliciano EM, Fumagalli IA, Caan B, Lenchik L, Popuri K, Chow V, Beg MF, Bhatia S, Williams GR. Giri S, et al. Among authors: hess d. J Cachexia Sarcopenia Muscle. 2024 Dec 23. doi: 10.1002/jcsm.13664. Online ahead of print. J Cachexia Sarcopenia Muscle. 2024. PMID: 39711205 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,639 results

Search Page

Filters